{"id":"W2102620699","doi":"10.1200/jco.2007.13.5822","title":"Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":533,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Exemestane; Medicine; Fulvestrant; Internal medicine; Aromatase inhibitor; Oncology; Placebo; Breast cancer; Adverse effect; Hazard ratio; Clinical endpoint; Cancer; Clinical trial; Aromatase; Tamoxifen; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002637596,0.002665934,0.00529243,0.0007504598,0.0007621069,0.001328486,0.001202157,0.002840734,0.01070891],"category_scores_gemma":[0.003116235,0.001126173,0.002310295,0.0005520781,0.002230809,0.001611884,0.0005914955,0.003257927,0.001728656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008398608,"about_ca_system_score_gemma":0.001630557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001070136,"about_ca_topic_score_gemma":0.002283501,"domain_scores_codex":[0.9988891,0.0005622557,0.00009900461,0.0002277253,0.0000716059,0.0001504034],"domain_scores_gemma":[0.9981717,0.0005518223,0.0003962049,0.0001760081,0.0001565362,0.000547581],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9942082,0.002544946,0.00007889932,0.0001799646,0.0002325371,0.000007795486,0.00001148725,0.00004937501,0.00057136,0.0000228805,0.0001602924,0.001932211],"study_design_scores_gemma":[0.9770408,0.02208072,0.0003019009,0.00001022023,0.0001319286,0.000005966497,0.0000060242,0.0001238413,0.0001095162,0.00004179131,0.0001418016,0.00000540471],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713228,0.007167564,0.001303825,0.001167077,0.002462547,0.01125234,0.002304012,0.0003316398,0.002688166],"genre_scores_gemma":[0.9690024,0.003641594,0.002445565,0.001751964,0.001475452,0.0130744,0.001684853,0.00005405163,0.006869728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01070891,"threshold_uncertainty_score":0.03582484,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02064290175474389,"score_gpt":0.3292825678814817,"score_spread":0.3086396661267379,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}